Ortho Visc Logo
red_line
FOLLOW US ON TWITTER | EMAIL TO A FRIEND  |  TEXT SIZE A | A | A
 
 
 
Send to a friend
This form allows you to send a URL to a friend of yours. Your friend will then receive an email with a link to this page.

By submitting an email address, you are requesting that we contact on your behalf the person you specify here. Your contact information and your friend's contact information are required, but they will not be used other than to distribute the communication you request.

* mandatory fields
     
red_curve

Important Safety Information

ORTHOVISC® is indicated in the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g. acetaminophen. In clinical studies, the most commonly reported adverse events were arthralgia, back pain, and headache. Other side effects included local injection site adverse events.

ORTHOVISC® is contraindicated in patients with known hypersensitivity to hyaluronate formulations or known hypersensitivity (allergy) to gram positive bacterial proteins. ORTHOVISC® should not be injected in patients with infections or skin diseases in the area of the injection site or joint. Strict aseptic technique should be used. The effectiveness of more than 1 course has not been established.